May 19, 2021
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, was cited as a source for an article published by NPR on whether people who have gotten vaccinated for COVID-19 should have their antibodies tested.
May 21, 2021
Message
May 25, 2021
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases was interviewed by two local TV stations for a story they did on myocarditis and COVID-19 vaccines. An advisory committee to the CDC is looking into reports that some teenagers and young adults who have received the COVID-19 vaccine have experienced heart inflammation. They’re reviewing these cases to see if there’s a possible connection.
September 17, 2021
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed by WLWT-TV for a story posted on MSN about the growing popularity of rapid tests for COVID-19. He said the accuracy of the tests is improving.
September 16, 2021
The University of Cincinnati is awarding prizes in the weekly ‘Strength in Immunity’ drawing. To further encourage vaccination against COVID-19, the university is conducting weekly drawings for gift cards in varying amounts of $2,500 or $5,000. In all, the university will award nearly $50,000.
September 8, 2021
The newest COVID-19 variant, Mu, is starting to cause concern, being found now in all 50 United States. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed by WLWT-TV about the latest on the Mu variant.
September 8, 2021
UC's Hilja R. Ruegg, MD, medical director of Integrated Mental Health Care and program director in the UC Family Medicine/Psychiatry Combined Training Program, spoke with Fox 19's Trevor Peters about the grassroots campaign of area physician moms encouraging schools to require universal masking.
September 2, 2021
Trisha Wise-Draper, MD, medical director of the UC Cancer Center's Clinical Trial Office and associate professor of medicine in the Division of Hematology/Oncology, spoke with Local 12's Liz Bonis about the latest research leading to the recommendation that cancer patients should receive a third dose of mRNA COVID-19 vaccines.
September 1, 2021
President Neville G. Pinto's message to the UC community regarding a vaccine requirement.
August 30, 2021
The University of Cincinnati has awarded its first round of prizes in the weekly ‘Strength in Immunity’ drawing, and WLWT interviewed faculty winner Christina Tan.
August 27, 2021
The school year rapidly approaches amid a surge in pediatric COVID-19 hospitalizations, and parents desperately want to know: When can young children get the vaccine? UC's Carl Fichtenbaum weighs in.
August 26, 2021
Researchers at the University of Cincinnati and UC Health have administered a first-of-its-kind potential COVID-19 therapy. The first dosing was administered to a patient at UC Medical Center in Cincinnati on Aug. 17.
August 24, 2021
UC President Neville Pinto's Statement on Vaccination
August 23, 2021
The first day of classes for the fall semester at the University of Cincinnati starts Monday, Aug. 23, and more than 46,700 students are expected to begin instruction with a more traditional fall term, focusing on in-person instruction and activities.
August 19, 2021
Carl Fichtenbaum, MD. of the UC College of Medicine Division of Infectious Diseases was interviewed by WKRC-TV, Local 12, on a story about presidential health advisors announcing that COVID-19 booster shots will soon be offered to all Americans. Pending FDA approval, beginning Sept. 20, third shots will be available for those who got the Pfizer or Moderna vaccines at least eight months ago.
August 17, 2021
Triple DDD
August 13, 2021
The FDA is now allowing a third dose of the vaccine in transplant patients and those who have compromised immunity to protect against COVID-19. UC transplant surgeon Steve Woodle, MD, spoke with Local 12 News about the new move from the federal government.
August 11, 2021
Researchers at the University of Cincinnati College of Medicine have developed a computerized decision analytic model to compare projected outcomes of three vaccine strategies: a patient opts for a messenger RNA vaccine, a patient decides to get an adenovirus vector vaccine or the patient simply forgoes a vaccine altogether.